In this clinical trial participant immune responses were predominantly seen to be mediated by CD4+ T cells, where as natural infection results in a predominant CD8+ T cell response, indicating the potential for variations between vaccine-induced immune responses and natural infection. The gene discussed is CD8A; the disease is infection.